Innovotech (CVE:IOT) Shares Up 11.1% – Should You Buy?

Innovotech Inc. (CVE:IOTGet Free Report) traded up 11.1% during trading on Monday . The company traded as high as C$0.20 and last traded at C$0.20. 10,000 shares were traded during trading, an increase of 158% from the average session volume of 3,880 shares. The stock had previously closed at C$0.18.

Innovotech Stock Performance

The stock has a 50-day moving average of C$0.18 and a 200 day moving average of C$0.15. The firm has a market capitalization of C$7.80 million, a P/E ratio of -20.00 and a beta of 1.15. The company has a debt-to-equity ratio of 12.55, a quick ratio of 5.81 and a current ratio of 2.63.

About Innovotech

(Get Free Report)

Innovotech Inc provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; MBEC Assay kit, a petri dish for biofilms, which are used for research and medical device testing of microbial biofilms; and AgreGuard, an antimicrobial for crop protection.

Read More

Receive News & Ratings for Innovotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovotech and related companies with MarketBeat.com's FREE daily email newsletter.